These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1500 related items for PubMed ID: 27490513

  • 1. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2012-2013.
    Mehta P, Kaye W, Bryan L, Larson T, Copeland T, Wu J, Muravov O, Horton K.
    MMWR Surveill Summ; 2016 Aug 05; 65(8):1-12. PubMed ID: 27490513
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, Centers for Disease Control and Prevention (CDC).
    MMWR Suppl; 2014 Jul 25; 63(7):1-14. PubMed ID: 25054277
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.
    Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, Nelson LM, Topol B, Han M, Muravov O, Genson C, Davis B, Hicks T, Horton K.
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May 25; 23(3-4):220-225. PubMed ID: 34423697
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
    Mehta P, Raymond J, Punjani R, Larson T, Han M, Bove F, Horton DK.
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug 25; 23(5-6):378-382. PubMed ID: 35023792
    [Abstract] [Full Text] [Related]

  • 7. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA, Centers for Disease Control and Prevention (CDC).
    MMWR Suppl; 2014 Oct 31; 63(4):3-27. PubMed ID: 25356673
    [Abstract] [Full Text] [Related]

  • 8. Prevalence of amyotrophic lateral sclerosis in the United States, 2018.
    Mehta P, Raymond J, Zhang Y, Punjani R, Han M, Larson T, Muravov O, Lyles RH, Horton DK.
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug 21; ():1-7. PubMed ID: 37602649
    [Abstract] [Full Text] [Related]

  • 9. Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    Bryan L, Kaye W, Antao V, Mehta P, Muravov O, Horton DK.
    PLoS One; 2016 Aug 21; 11(4):e0153683. PubMed ID: 27124833
    [Abstract] [Full Text] [Related]

  • 10. Feasibility of creating a National ALS Registry using administrative data in the United States.
    Kaye WE, Sanchez M, Wu J.
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep 21; 15(5-6):433-9. PubMed ID: 24597459
    [Abstract] [Full Text] [Related]

  • 11. Estimation of the Prevalence of Amyotrophic Lateral Sclerosis in the United States Using National Administrative Healthcare Data from 2002 to 2004 and Capture-Recapture Methodology.
    Nelson LM, Topol B, Kaye W, Williamson D, Horton DK, Mehta P, Wagner T.
    Neuroepidemiology; 2018 Sep 21; 51(3-4):149-157. PubMed ID: 30092573
    [Abstract] [Full Text] [Related]

  • 12. CDC Grand Rounds: National Amyotrophic Lateral Sclerosis (ALS) Registry Impact, Challenges, and Future Directions.
    Mehta P, Horton DK, Kasarskis EJ, Tessaro E, Eisenberg MS, Laird S, Iskander J.
    MMWR Morb Mortal Wkly Rep; 2017 Dec 22; 66(50):1379-1382. PubMed ID: 29267263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method.
    Nelson LM, Topol B, Kaye W, Raymond J, Horton DK, Mehta P, Wagner T.
    Neuroepidemiology; 2022 Dec 22; 56(2):104-114. PubMed ID: 34929703
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of Amyotrophic Lateral Sclerosis - United States, 2014.
    Mehta P, Kaye W, Raymond J, Wu R, Larson T, Punjani R, Heller D, Cohen J, Peters T, Muravov O, Horton K.
    MMWR Morb Mortal Wkly Rep; 2018 Feb 23; 67(7):216-218. PubMed ID: 29470458
    [Abstract] [Full Text] [Related]

  • 16. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.
    Epidemiol Prev; 2016 Feb 23; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [Abstract] [Full Text] [Related]

  • 17. State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.
    Wagner L, Rechtman L, Jordan H, Ritsick M, Sanchez M, Sorenson E, Kaye W.
    Amyotroph Lateral Scler Frontotemporal Degener; 2015 Feb 23; 17(1-2):128-34. PubMed ID: 26399278
    [Abstract] [Full Text] [Related]

  • 18. Malaria surveillance--United States, 2011.
    Cullen KA, Arguin PM, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC).
    MMWR Surveill Summ; 2013 Nov 01; 62(5):1-17. PubMed ID: 24172939
    [Abstract] [Full Text] [Related]

  • 19. Surveillance for Sickle Cell Disease - Sickle Cell Data Collection Program, Two States, 2004-2018.
    Snyder AB, Lakshmanan S, Hulihan MM, Paulukonis ST, Zhou M, Horiuchi SS, Abe K, Pope SN, Schieve LA.
    MMWR Surveill Summ; 2022 Oct 07; 71(9):1-18. PubMed ID: 36201430
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.